Mawar Izzati Nadilla, . (2023) PENGARUH PENGGUNAAN STATIN TERHADAP TINGKAT KEPARAHAN PASIEN COVID-19 DENGAN KOMORBIDITAS: Sebuah Tinjauan Sistematis. Tesis thesis, Universitas Pembangunan Nasional Veteran Jakarta.
Text
ABSTRAK.pdf Download (489kB) |
|
Text
AWAL.pdf Download (2MB) |
|
Text
BAB 1.pdf Download (420kB) |
|
Text
BAB 2.pdf Restricted to Repository UPNVJ Only Download (796kB) |
|
Text
BAB 3.pdf Restricted to Repository UPNVJ Only Download (367kB) |
|
Text
BAB 4.pdf Restricted to Repository UPNVJ Only Download (555kB) |
|
Text
BAB 5.pdf Download (304kB) |
|
Text
DAFTAR PUSTAKA.pdf Download (436kB) |
|
Text
RIWAYAT HIDUP.pdf Restricted to Repository UPNVJ Only Download (319kB) |
|
Text
LAMPIRAN.pdf Restricted to Repository UPNVJ Only Download (727kB) |
|
Text
HASIL PLAGIARISME.pdf Restricted to Repository staff only Download (422kB) |
|
Text
ARTIKEL KI.pdf Restricted to Repository staff only Download (245kB) |
Abstract
Introduction: The severity of COVID-19 patients is influenced by several things, one of which is comorbidity. The most common comorbidities are atherosclerosis and hypertension associated with endothelial dysfunction. Several studies stated that one of the drugs routinely used by comorbid patients, statins, has a pleiotropic effect as an anti-inflammatory and vasculoprotector. We are interested in examining the effect of statin use on the severity of COVID-19 patients with comorbidities through four indicators, there are clinical symptoms, need for mechanical ventilation and intensive care units, and CRP levels. Methods: A systematic review using secondary data from literature obtained from the Google Scholar, EBSCO, Science Direct, and Pubmed databases using the PRISMA method from July 2022 to January 2023. Results: Eight journals reviewed, four of them stated that statins had an effect in reducing the severity of COVID-19 patients with comorbidities, three journals did not find a significant difference in severity, and one journal showed that statins increased the severity of COVID-19 patients with comorbidities. Conclusion: The use of statins can reduce the severity of COVID-19 patients with comorbidities.
Item Type: | Thesis (Tesis) |
---|---|
Additional Information: | [No.Panggil: 1810211044] [Pembimbing 1: Hany Yusmaini] [Pembimbing 2: Diana Agustini P] [Penguji: Melly Kristanti] |
Uncontrolled Keywords: | COVID-19, Statin, Severity, Comorbidities |
Subjects: | R Medicine > R Medicine (General) R Medicine > RM Therapeutics. Pharmacology |
Divisions: | Fakultas Kedokteran > Program Studi Kedokteran (S1) |
Depositing User: | Mawar Izzati Nadilla |
Date Deposited: | 27 Feb 2023 08:42 |
Last Modified: | 27 Feb 2023 08:42 |
URI: | http://repository.upnvj.ac.id/id/eprint/23147 |
Actions (login required)
View Item |